- Home
- BIAF vs PRHI Comparison
BIAF vs PRHI Comparison
Compare BIAF & PRHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- PRHI
- Stock Information
- Founded
- BIAF 2014
- PRHI 2009
- Country
- BIAF United States
- PRHI United States
- Employees
- BIAF N/A
- PRHI N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PRHI Property-Casualty Insurers
- Sector
- BIAF Health Care
- PRHI Finance
- Exchange
- BIAF Nasdaq
- PRHI Nasdaq
- Market Cap
- BIAF 13.0M
- PRHI 13.7M
- IPO Year
- BIAF 2022
- PRHI N/A
- Fundamental
- Price
- BIAF $2.49
- PRHI $1.45
- Analyst Decision
- BIAF Hold
- PRHI
- Analyst Count
- BIAF 1
- PRHI 0
- Target Price
- BIAF N/A
- PRHI N/A
- AVG Volume (30 Days)
- BIAF 3.3M
- PRHI 2.1M
- Earning Date
- BIAF 11-13-2025
- PRHI 11-12-2025
- Dividend Yield
- BIAF N/A
- PRHI N/A
- EPS Growth
- BIAF N/A
- PRHI N/A
- EPS
- BIAF N/A
- PRHI 2.45
- Revenue
- BIAF $7,681,059.00
- PRHI $52,654,000.00
- Revenue This Year
- BIAF N/A
- PRHI $25.91
- Revenue Next Year
- BIAF $20.04
- PRHI N/A
- P/E Ratio
- BIAF N/A
- PRHI $0.60
- Revenue Growth
- BIAF 4.99
- PRHI N/A
- 52 Week Low
- BIAF $2.34
- PRHI $0.42
- 52 Week High
- BIAF $46.53
- PRHI $2.83
- Technical
- Relative Strength Index (RSI)
- BIAF 46.54
- PRHI N/A
- Support Level
- BIAF $2.43
- PRHI N/A
- Resistance Level
- BIAF $3.50
- PRHI N/A
- Average True Range (ATR)
- BIAF 0.29
- PRHI 0.00
- MACD
- BIAF -0.09
- PRHI 0.00
- Stochastic Oscillator
- BIAF 5.69
- PRHI 0.00
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.